Tag: NTI drugs
Prescriber Attitudes Toward NTI Drugs and Substitution: What Doctors Really Think
Prescribers remain cautious about substituting generic versions of narrow therapeutic index (NTI) drugs due to risks of toxicity or therapeutic failure. Despite FDA assurances, doctors, pharmacists, and patients face real-world challenges in ensuring safety and stability.
Continue Reading
